Aptevo Therapeutics (APVO) shares slumped nearly 34% in recent trading Thursday after the company announced the exercise of its warrants at a discount.
Holders of the company's previously issued warrants agreed to exercise the securities for 823,544 shares at $7.50 apiece, netting Aptevo $6.2 million in gross proceeds.
Aptevo will also issue new warrants to the investors to buy up to 1,647,088 shares at an exercise price of $9.53, it said.
Aptevo said it will use the funds for working capital and general corporate purposes. The offering is expected to close by Friday.
Price: 6.65, Change: -3.36, Percent Change: -33.57
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。